Login / Signup

Effects of prenatal opioid exposure on infant sympathetic and parasympathetic nervous system activity.

Alexandra R TabachnickRina Das EidenMadelyn H LabellaMary Dozier
Published in: Psychophysiology (2023)
Prenatal opioid exposure has been associated with developmental problems, including autonomic nervous system dysregulation. However, little is known about the effects of prenatal opioid exposure on the autonomic nervous system beyond the first days of life, particularly across both the parasympathetic and sympathetic branches, and when accounting for exposure to other substances. The present study examined the effects of prenatal exposure to opioid agonist therapy (OAT, e.g., methadone) and other opioids on infant autonomic nervous system activity at rest and in response to a social stressor (the Still-Face Paradigm) at six months among 86 infants varying in prenatal opioid and other substance exposure. Results indicated that OAT and other opioids have unique effects on the developing autonomic nervous system that may further depend on subtype (i.e., methadone versus buprenorphine) and timing in gestation. Results are discussed in the context of theoretical models of the developing stress response system.
Keyphrases
  • chronic pain
  • pain management
  • heart rate variability
  • pregnant women
  • heart rate
  • mental health
  • healthcare
  • preterm infants
  • stem cells
  • bone marrow
  • gestational age
  • smoking cessation
  • cell therapy